BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27432893)

  • 1. The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis.
    Zhou J; You W; Sun G; Li Y; Chen B; Ai J; Jiang H
    J Pharmacol Exp Ther; 2016 Oct; 359(1):54-61. PubMed ID: 27432893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
    Dong F; Liu T; Jin H; Wang W
    Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
    Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor.
    Park SJ; Choi YS; Lee S; Lee YJ; Hong S; Han S; Kim BC
    Cancer Lett; 2016 Oct; 381(2):314-22. PubMed ID: 27543359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma.
    Jiang X; Zhang Z; Song C; Deng H; Yang R; Zhou L; Sun Y; Zhang Q
    Chem Biol Interact; 2019 Jul; 307():158-166. PubMed ID: 31059706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.
    Park CY; Kim DK; Sheen YY
    Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-β1-induced epithelial-to-mesenchymal transition.
    Wang Y; Wang H; Zhou R; Zhong W; Lu S; Ma Z; Chai Y
    Anticancer Drugs; 2017 Jul; 28(6):581-587. PubMed ID: 28379900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salinomycin suppresses TGF-β1-induced epithelial-to-mesenchymal transition in MCF-7 human breast cancer cells.
    Zhang C; Lu Y; Li Q; Mao J; Hou Z; Yu X; Fan S; Li J; Gao T; Yan B; Wang B; Song B; Li L
    Chem Biol Interact; 2016 Mar; 248():74-81. PubMed ID: 26896736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion.
    Lim WC; Kim H; Kim YJ; Choi KC; Lee IH; Lee KH; Kim MK; Ko H
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3342-3348. PubMed ID: 28610976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
    Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
    Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
    Kim YJ; Jeon Y; Kim T; Lim WC; Ham J; Park YN; Kim TJ; Ko H
    Bioorg Med Chem Lett; 2017 Feb; 27(4):1081-1088. PubMed ID: 28110870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.
    Chen Y; Liu W; Wang P; Hou H; Liu N; Gong L; Wang Y; Ji K; Zhao L; Wang P
    Oncotarget; 2016 Nov; 7(44):71341-71352. PubMed ID: 27533085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
    Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MS80, a novel sulfated oligosaccharide, inhibits pulmonary fibrosis by targeting TGF-beta1 both in vitro and in vivo.
    Jiang HD; Guan HS
    Acta Pharmacol Sin; 2009 Jul; 30(7):973-9. PubMed ID: 19543300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
    Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
    J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
    Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
    Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
    Sun Y; Zhou QM; Lu YY; Zhang H; Chen QL; Zhao M; Su SB
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30901941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.